Literature DB >> 2850195

Phase II study of ifosfamide (Holoxan) in hepatoma.

S Thongprasert1, K Klunklin, K Phornphutkul, O A Prisontarangkul, B Chaimongkol, B Sivasomboon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2850195     DOI： 10.1016/0277-5379(88)90084-3

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN： 0277-5379


× No keyword cloud information.
  1 in total

1.  Phase II study of high-dose ifosfamide in hepatocellular carcinoma.

Authors:  J Lin; W Shiu; W T Leung; M Tao; N Leung; W Y Lau; A K Li
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.